Radiation Oncology

Publications

• ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT.

  (Damico N, Meyer J, Das P, Murphy J, Miller E, Koontz B, Hall W, McBride M, Pereira G, Catalano P, Chakravarthy AB, O'Dwyer PJ, Dorth J.) Pract Radiat Oncol. 2022 Jul-Aug;12(4):335-347 PMID: 35717050 SCOPUS ID: 2-s2.0-85132239599 06/19/2022

• A prior knowledge guided deep learning based semi-automatic segmentation for complex anatomy on MRI.

  (Zhang Y, Liang Y, Ding J, Amjad A, Paulson E, Ahunbay E, Hall WA, Erickson B, Li XA.) Int J Radiat Oncol Biol Phys. 2022 Jun 03 PMID: 35667525 06/07/2022

• First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac.

  (Janssen TM, Aitken K, Alongi F, Barry A, Bernchou U, Boeke S, Hall WA, Hosni A, Kroon PS, Nachbar M, Saeed H, Jürgenliemk-Schulz IM, Schytte T, Verkooijen HM, Nowee ME, tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium.) Tech Innov Patient Support Radiat Oncol. 2022 Jun;22:50-54 PMID: 35586786 PMCID: PMC9108982 05/20/2022

• Adaptive radiation therapy physician guidelines: Recommendations from an expert users' panel.

  (Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L.) Pract Radiat Oncol. 2022 May 26 PMID: 35644469 06/02/2022

• General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis.

  (Amjad A, Xu J, Thill D, Lawton C, Hall W, Awan MJ, Shukla M, Erickson BA, Li XA.) Med Phys. 2022 Mar;49(3):1686-1700 PMID: 35094390 PMCID: PMC8917093 SCOPUS ID: 2-s2.0-85124464974 01/31/2022

• Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.

  (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium.) Radiother Oncol. 2022 03;168:75-82 PMID: 35077710 PMCID: PMC8986577 SCOPUS ID: 2-s2.0-85123912429 01/26/2022

• Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.

  (Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM.) J Gastrointest Oncol. 2022 Feb;13(1):185-196 PMID: 35284138 PMCID: PMC8899735 03/15/2022

• Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation

  (Gough J, Hall W, Good J, Nash A, Aitken K.) Clinical Oncology. May 2022;34(5):301-312 SCOPUS ID: 2-s2.0-85126523768 05/01/2022

• Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer

  (Beltrán Ponce SE, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM.) Journal of Gastrointestinal Oncology. February 2022;13(1):185-196 SCOPUS ID: 2-s2.0-85125562951 02/01/2022

• Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126

  (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B.) International Journal of Radiation Oncology Biology Physics. 1 January 2022;112(1):83-92 SCOPUS ID: 2-s2.0-85120798535 01/01/2022

• Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.

  (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B.) Int J Radiat Oncol Biol Phys. 2022 01 01;112(1):83-92 PMID: 34919884 PMCID: PMC8789217 SCOPUS ID: 2-s2.0-85120798535 12/18/2021

• Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.

  (Daamen LA, de Mol van Otterloo SR, van Goor IWJM, Eijkelenkamp H, Erickson BA, Hall WA, Heerkens HD, Meijer GJ, Molenaar IQ, van Santvoort HC, Verkooijen HM, Intven MPW.) Acta Oncol. 2022 Jan;61(1):111-115 PMID: 34879792 SCOPUS ID: 2-s2.0-85121352408 12/10/2021